Contact

Category: False Claims Act

Posted in
Posted in

FCA Case Spotlight: District of Massachusetts Finds Insufficient Evidence of Remuneration or Willfulness in Janssen’s Infusion-Suite Support Programs

By 0 on FCA Case Spotlight: District of Massachusetts Finds Insufficient Evidence of Remuneration or Willfulness in Janssen’s Infusion-Suite Support Programs

United States ex rel. Long v. Janssen Biotech, Inc., No. 1:16-cv-12182-FDS, 2026 WL 2949353 (D. Mass. Sept. 30, 2026) Healthcare / False Claims Act · Anti-Kickback Statute · Manufacturer Practice Support · Scienter Introduction Manufacturers of physician-administered drugs have long supported the practices that administer them, with reimbursement hotlines, coding guides, nurse training, and advice […]

CONTINUE READING FCA Case Spotlight: District of Massachusetts Finds Insufficient Evidence of Remuneration or Willfulness in Janssen’s Infusion-Suite Support Programs 13 min read
Posted in
Posted in

FCA Case Spotlight: An Indiana Federal Court Holds That Medicaid’s Failure to Recoup Contractor-Flagged Overpayments Does Not Defeat Materiality at the Pleading Stage

By 0 on FCA Case Spotlight: An Indiana Federal Court Holds That Medicaid’s Failure to Recoup Contractor-Flagged Overpayments Does Not Defeat Materiality at the Pleading Stage

United States ex rel. McCullough v. Anthem Insurance Companies, Inc., No. 1:21-cv-00325-TWP-TAB, 2026 WL 2448954 (S.D. Ind. Aug. 20, 2026) Healthcare / False Claims Act · Medicaid Managed Care · Materiality · Government Knowledge Introduction In Universal Health Services, Inc. v. United States ex rel. Escobar, 579 U.S. 176, 194 (2016), the Supreme Court held […]

CONTINUE READING FCA Case Spotlight: An Indiana Federal Court Holds That Medicaid’s Failure to Recoup Contractor-Flagged Overpayments Does Not Defeat Materiality at the Pleading Stage 16 min read
Posted in
Posted in

FCA Case Spotlight: The Ninth Circuit Holds That a $200 Million HUD Compliance Agreement Was Not an “Alternate Remedy” and Affirms a $38.3 Million Qui Tam Settlement

By 0 on FCA Case Spotlight: The Ninth Circuit Holds That a $200 Million HUD Compliance Agreement Was Not an “Alternate Remedy” and Affirms a $38.3 Million Qui Tam Settlement

United States ex rel. Ling v. City of Los Angeles, No. 25-249, ___ F.4th ___, 2026 WL 2871734 (9th Cir. Sept. 24, 2026) | United States ex rel. Novak v. Walgreens Boots Alliance, Inc., No. 18 C 5452, 2026 WL 2920869 (N.D. Ill. Sept. 29, 2026) False Claims Act · Qui Tam Settlement Approval · […]

CONTINUE READING FCA Case Spotlight: The Ninth Circuit Holds That a $200 Million HUD Compliance Agreement Was Not an “Alternate Remedy” and Affirms a $38.3 Million Qui Tam Settlement 17 min read
Posted in
Posted in

FCA Case Spotlight: The Ninth Circuit Revives a 340B Covered Entity’s False Claims Act Suit Against Four Drug Manufacturers

By 0 on FCA Case Spotlight: The Ninth Circuit Revives a 340B Covered Entity’s False Claims Act Suit Against Four Drug Manufacturers

The Ninth Circuit revives a 340B qui tam suit, holding that the FCA remains an independent enforcement mechanism even where the underlying statute lacks a private right of action.

CONTINUE READING FCA Case Spotlight: The Ninth Circuit Revives a 340B Covered Entity’s False Claims Act Suit Against Four Drug Manufacturers 12 min read
Posted in
Posted in

FCA Alert: The Eleventh Circuit Rejects the Appointments Clause Challenge to Qui Tam — and Remands Two Constitutional Questions

By 0 on FCA Alert: The Eleventh Circuit Rejects the Appointments Clause Challenge to Qui Tam — and Remands Two Constitutional Questions

United States ex rel. Zafirov v. Florida Medical Associates, LLC, No. 24-13581, slip op. (11th Cir. Sept. 1, 2026) (published) | vacating and remanding United States ex rel. Zafirov v. Florida Medical Associates, LLC, 751 F. Supp. 3d 1293 (M.D. Fla. 2024) Healthcare / False Claims Act — qui tam constitutionality (Appointments Clause) Introduction The […]

CONTINUE READING FCA Alert: The Eleventh Circuit Rejects the Appointments Clause Challenge to Qui Tam — and Remands Two Constitutional Questions 9 min read
Posted in
Posted in

FCA Cases – Quarterly Summary by FCA Section (2026 Q2)

By 0 on FCA Cases – Quarterly Summary by FCA Section (2026 Q2)

Compiled from Westlaw WestClip FCA alerts covering April 1 – June 30, 2026. This document covers the second quarter of 2026 (April 1 – June 30, 2026), continuing the quarterly False Claims Act case summaries. Cases are categorized by statutory provision, with Westlaw citations, courts, and decision dates after each case name. Coverage focuses on […]

CONTINUE READING FCA Cases – Quarterly Summary by FCA Section (2026 Q2) 8 min read
Posted in
Posted in

FCA Cases – Quarterly Summary by FCA Section (2025 Q3 – 2026 Q1)

By 0 on FCA Cases – Quarterly Summary by FCA Section (2025 Q3 – 2026 Q1)

Compiled from Westlaw WestClip FCA alerts covering July 1, 2025 through March 31, 2026. This post collects False Claims Act decisions from three quarters — 2025Q3 through 2026Q1 — organized by the statutory provision each decision construes. Westlaw citations, courts, and decision dates follow each case name. Coverage focuses on decisions that bear on an […]

CONTINUE READING FCA Cases – Quarterly Summary by FCA Section (2025 Q3 – 2026 Q1) 21 min read
Posted in
Posted in

FCA Case Spotlight: FCA Scienter After Schutte — Sheldon v. Allergan & White v. Gainwell

By 0 on FCA Case Spotlight: FCA Scienter After Schutte — Sheldon v. Allergan & White v. Gainwell

Sheldon: No. ELH-14-2535, 2026 WL 1868781 (D. Md. June 29, 2026) | White: 2026 WL 1864033 (D. Mass. June 29, 2026) Executive Summary Decided on the same day, United States ex rel. Sheldon v. Allergan Sales, LLC and United States ex rel. White v. Gainwell Technologies LLC are two district-court opinions applying the Supreme Court’s […]

CONTINUE READING FCA Case Spotlight: FCA Scienter After Schutte — Sheldon v. Allergan & White v. Gainwell 6 min read
Posted in
Posted in

FCA Case Spotlight: United States ex rel. Kyer v. Thomas Health System, Inc.

By 0 on FCA Case Spotlight: United States ex rel. Kyer v. Thomas Health System, Inc.

No. 25-1507, — F.4th —-, 2026 WL 1595887 (4th Cir. June 4, 2026) Executive Summary In United States ex rel. Kyer v. Thomas Health System, Inc., the Fourth Circuit Court of Appeals affirmed the dismissal of a qui tam False Claims Act (FCA) suit brought by a former hospital nurse against a nonprofit health system, […]

CONTINUE READING FCA Case Spotlight: United States ex rel. Kyer v. Thomas Health System, Inc. 6 min read
Contact